GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,702,136 | -12.8% | 2,733,800 | -1.1% | 0.19% | +0.5% |
| Q2 2023 | $5,392,725 | +133.8% | 2,765,500 | +393.8% | 0.19% | +291.7% |
| Q1 2022 | $2,307,000 | -95.9% | 560,000 | -87.2% | 0.05% | -96.0% |
| Q4 2021 | $56,198,000 | +16.7% | 4,370,000 | -2.0% | 1.19% | +11.7% |
| Q3 2021 | $48,145,000 | +148.5% | 4,457,831 | +110.1% | 1.07% | +103.6% |
| Q2 2021 | $19,374,000 | -3.2% | 2,122,064 | 0.0% | 0.52% | -5.2% |
| Q1 2021 | $20,011,000 | +139.3% | 2,122,064 | 0.0% | 0.55% | +104.1% |
| Q4 2020 | $8,361,000 | – | 2,122,064 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |